Radium-223 Plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results
Oncologist 2021 Dec 01;26(12)1006-e2129, BL Maughan, A Kessel, TR McFarland, N Sayegh, R Nussenzveig, AW Hahn, JM Hoffman, K Morton, D Sirohi, M Kohli, U Swami, K Boucher, B Haaland, N AgarwalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.